China Healthcare Weekly (Mar.31) - 8th National VBP Result, Chinese Patent Medicine VBP, AIM Vaccine
⬇ $AIM Vaccine(06660)$ - The 8th national VBP released results.The impact of VBP on companies is decreasing. Chinese patent medicine VBP is coming, but some companies can cope well.AIM doesn’t have long-term investment value.
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/china-healthcare-weekly-mar-31-8th-national-vbp-result-chinese-patent-medicine-vbp-aim-vaccine?utm_source=tiger_community
By Xinyao (Criss) Wang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/xinyao-criss-wang?utm_source=tiger_community
On AIM Vaccine (06660):- https://www.smartkarma.com/entities/aim-vaccine-co-ltd?utm_source=tiger_community
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- ramius75·2023-04-04👌LikeReport
- Jackwoft·2023-04-02OkLikeReport
- StarryA·2023-04-02👏LikeReport
- Brocco·2023-04-02KLikeReport
- Cris0·2023-04-02KLikeReport
- DarkFate·2023-04-02LikeLikeReport